About

Gentle products, hard science, strong team

Determination. Dedication. Daring.

Odd Erik Hansen
Odd Erik Hansen
Chief Executive Officer
Odd has supported several midsize and large food ingredient and biotech companies as an advisor in strategic and operational matters – working at McKinsey, Bain and Company, and as an independent.

He co-founded Bain’s Copenhagen Office.
Jesper Mørk
Jesper Mørk
Chief Technology Officer
Jesper has served as head of Global Engineering at both Chr. Hansen and H. Lundbeck. He also led the design and commissioning of the Biogen Idec facility in Denmark.

Jesper also served as Business and Process adviser at NNE Pharmaplan.
Bruce McConnell
Bruce McConnell
Head of Business Development
Bruce has served as the head of business development / innovation for several Nestlé businesses, on the Nestlé venture board and on the board of several health care start ups and JV’s.

Previously in business development for Sandoz Pharma and in consulting.
Carsten Gram Andersen
Carsten Gram Andersen
Chief Financial Officer
Carsten has 25+ years of experience with Finance and Accounting in global companies most recently as Vice President, Group Finance with H. Lundbeck A/S, and before this in financial leadership roles with A.P. Møller-Mærsk and J.M. Huber Corp.

He has extensive experience with M&A's, ERP implementations, business process re-engineering, as well as outsourcing initiatives.
Niels Banke
Niels Banke
Chief Science Officer
Niels has been working +25 years at Novo Nordisk and Novozymes in R&D, where he was head of fermentation process development in Denmark and brought over 100 strains from the lab into production.
Kjeld Kjeldsen
Kjeld Kjeldsen
Site Director - Esbjerg
Kjeld has been working with biotechnological manufacturing for the last 12 years.

Kjeld has been leading the Esbjerg site the last 6 years. The site has a track record of continuous improvements.
Thomas Kabel
Thomas Kabel
Executive Vice President, Corporate Development & M&A
Thomas has an M&A and finance background, and has helped biotech Novozymes grow through strategic acquisitions and partnership agreements.

Prior to this, Thomas was Vice President in the Danish investment bank, FIH Partners.

Who we are

Learn more
Our website uses cookies We will ask you to consent to our use of cookies in accordance with the terms of this policy read more
Ok